• Username (E-mail)
  • Password
Dow 19,827 0.5%  EStoxx50 3,285 -0.4%  Nikkei 18,891 -1.3%  EUR 1.0739 0.3% 
Nasdaq 5,555 0.3%  FTSE100 7,156 -0.6%  Yen 113.5080 -0.7%  Oil 55.0 -1.0% 
S&P500 2,271 0.3%  DAX 11,583 -0.4%  GBP 1.2462 0.7%  Gold 1,214 1.8% 

Johnson & Johnson share [Symbol: JNJ / ISIN: US4781601046]

Realtimequote Johnson & Johnson in USD

Exchange Market
114.13
Last
0
Volume
Time 03:59 PM
01/20/2017 03:59:59 PM UTC-0500
activate push

Stock Price Johnson & Johnson in USD

Activate push
114.15 USD -0.05 USD -0.04 %
Trade Time 4:15 PM Trade Date 1/20/2017
Daily High 0.00 Open 0.00
Daily Low 0.00 Prev. Close 114.15
52-week High 126.07 Volume (Qty.) 0
52-week Low 95.95 Market Cap (USD) 312.29 B
52-week Perf.
Exchange

Analyst Opinions for Johnson & Johnson

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
06/13/16
Johnson & Johnson Goldman Sachs Group Inc.
01/27/16
Johnson & Johnson Independent Research GmbH
01/21/16
Johnson & Johnson Independent Research GmbH
07/02/14
Johnson & Johnson Barclays Capital
11/25/13
Johnson & Johnson Independent Research GmbH

Moody's Rating for Johnson & Johnson

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating Aaa
Rating Update AFF
Date of Rating 10/13/2015
Rating Office USA

Profile Johnson & Johnson

Company Profile
Johnson & Johnson operates as an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company, through its subsidiaries operates in three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes a range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
pagehit

Add or Edit Instrument

Johnson & Johnson Chart - 1 Year - NYSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: NYSE
  • Chart Options

Estimates for Johnson & Johnson

2015 2016e 2017e
Dividend 2.95 3.13 3.33
Dividend Yield in % 2.87 2.70 2.87
P/E Ratio 16.59 17.32 16.31
EPS 6.20 6.70 7.12

Johnson & Johnson Key Figures

Market Cap (USD) 312.29 B
Free Float in % 99.91
Number of Shares (Mio.) 2,720.53
Cash Flow per Share 6.85
Book Value per Share 25.84
60-Days Volatility 15.86
P/B Ratio 3.98

Base Data Johnson & Johnson

Symbol JNJ
ISIN US4781601046
Indices S&P 100, NYSE US 100, Dow Jones, BX Swiss - USA, S&P 500

About the Company Johnson & Johnson

Country USA

Johnson & Johnson Historical Prices

01/19/2017
01/19/2017 06:00:00 PM UTC-0500
114.15 3,413,646
01/18/2017
01/18/2017 06:00:00 PM UTC-0500
114.20 1,665,301
01/17/2017
01/17/2017 06:00:00 PM UTC-0500
114.70 1,504,002
01/16/2017
01/16/2017 06:00:00 PM UTC-0500
114.87 2,206,695
01/12/2017
01/12/2017 06:00:00 PM UTC-0500
114.60 1,837,691

Johnson & Johnson Peer Group

Abbott Laboratories 40.46
0.1%
Alexion Pharmaceuticals 131.97
-1.8%
AstraZeneca 42.70
-1.1%
Bayer 101.55
-0.6%
Beiersdorf 81.87
0.0%
Celgene 112.66
-0.8%
Fresenius Medical Care 75.66
-0.3%
Fresenius 73.90
-0.2%
Fresenius 73.90
-0.2%
Fresenius 73.90
-0.2%
GlaxoSmithKline 15.31
-0.9%
Johnson & Johnson 114.15
0.0%
Merck 62.53
3.6%
Merck 101.60
-1.1%
MorphoSys 48.10
-0.5%
Nestle SA 73.20
-0.2%
Novartis 70.20
-0.8%
Pfizer 31.77
0.2%
Procter & Gamble 87.45
3.2%
Roche 235.10
-0.3%
STADA Arzneimittel 47.61
-0.9%
Sanofi 75.37
-0.4%
Unilever 39.03
0.1%

Similar shares with higher 1-year perf.